Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary transfusion reactions.

David F Stroncek1

  • 1Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892-1184, USA. dstroncek@cc.nih.gov

Seminars in Hematology
|January 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.

Journal for immunotherapy of cancer·2026
Same author

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse.

Cell·2026
Same author

Bringing in vivo CAR to the clinic: Promise, pitfalls, and questions to ask.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndrome.

British journal of haematology·2026
Same author

Alpha-gal sensitization and allergic blood transfusion reactions: a scoping review.

Journal of translational medicine·2026
Same author

Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia.

Blood advances·2025
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Pulmonary transfusion reactions are serious complications. While some are understood, acute lung injury and ARDS causes remain unclear, necessitating further research into leukocyte antibodies and other factors.

Area of Science:

  • Hematology
  • Pulmonology
  • Immunology

Background:

  • Transfusion reactions are common, with lung involvement being particularly severe.
  • Mechanisms include fluid overload, antibody-protein interactions, and microemboli, which are generally understood and preventable.
  • Acute lung injury and ARDS following transfusion present challenges due to poorly understood etiologies.

Purpose of the Study:

  • To review the mechanisms of pulmonary transfusion reactions.
  • To highlight the distinction between understood and poorly understood causes of lung injury post-transfusion.
  • To emphasize the need for further research into the role of leukocyte antibodies and other factors in transfusion-related acute lung injury.

Main Methods:

  • Literature review and synthesis of existing knowledge on pulmonary transfusion reactions.

Related Experiment Videos

  • Analysis of known mechanisms causing lung injury during transfusion.
  • Identification of knowledge gaps regarding transfusion-associated acute lung injury and ARDS.

    • Main Results:

    • Pulmonary edema, bronchospasm, anaphylaxis, and microemboli are understood causes of pulmonary transfusion reactions.
    • The precise mechanisms leading to transfusion-associated acute lung injury and ARDS are not fully elucidated.
    • Leukocyte antibodies are implicated in some reactions, but their exact role requires further investigation.

    Conclusions:

    • While some pulmonary transfusion reactions are well-understood, others, like transfusion-associated acute lung injury and ARDS, require more research.
    • Understanding the role of neutrophil and other leukocyte antibodies is crucial.
    • Prospective studies are needed to clarify the contribution of donor, component, and recipient factors to pulmonary transfusion reactions.